Northern Trust Corp Glaukos Corp Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Glaukos Corp stock. As of the latest transaction made, Northern Trust Corp holds 538,621 shares of GKOS stock, worth $74.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

538,621

Previous 520,906 3.4%

Holding current value

$74.7 Million

Previous $61.6 Million 13.82%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$113.62 - $135.39 $2.01 Million - $2.4 Million	17,715 Added 3.4%	538,621 $70.2 Million
Q2 2024 Aug 14, 2024	SELL	$89.48 - $118.35 $1.07 Million - $1.41 Million	-11,911 Reduced 2.24%	520,906 $61.6 Million
Q1 2024 May 14, 2024	SELL	$76.4 - $96.33 $755,672 - $952,800	-9,891 Reduced 1.82%	532,817 $50.2 Million
Q4 2023 Feb 13, 2024	SELL	$59.53 - $85.11 $572,023 - $817,821	-9,609 Reduced 1.74%	542,708 $43.1 Million
Q3 2023 Nov 13, 2023	BUY	$69.23 - $79.09 $172,382 - $196,934	2,490 Added 0.45%	552,317 $41.6 Million
Q2 2023 Aug 11, 2023	BUY	$45.44 - $71.21 $454,354 - $712,028	9,999 Added 1.85%	549,827 $39.2 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $164,637 - $196,904	3,752 Added 0.7%	539,828 $27 Million
Q4 2022 Feb 13, 2023	BUY	$40.82 - $57.75 $160,096 - $226,495	3,922 Added 0.74%	536,076 $23.4 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $1,358 - $1,696	29 Added 0.01%	532,154 $28.3 Million
Q2 2022 Aug 12, 2022	SELL	$34.86 - $63.77 $376,627 - $688,971	-10,804 Reduced 1.99%	532,125 $24.2 Million
Q1 2022 May 13, 2022	SELL	$44.33 - $57.82 $923,615 - $1.2 Million	-20,835 Reduced 3.7%	542,929 $31.4 Million
Q4 2021 Feb 08, 2022	SELL	$40.27 - $56.99 $196,477 - $278,054	-4,879 Reduced 0.86%	563,764 $25.1 Million
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $20,774 - $36,892	438 Added 0.08%	568,643 $27.4 Million
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $3.88 Million - $5.19 Million	53,129 Added 10.31%	568,205 $48.2 Million
Q1 2021 May 12, 2021	BUY	$70.43 - $97.42 $319,400 - $441,799	4,535 Added 0.89%	515,076 $43.2 Million
Q4 2020 Feb 11, 2021	SELL	$48.9 - $75.26 $629,489 - $968,821	-12,873 Reduced 2.46%	510,541 $38.4 Million
Q3 2020 Nov 16, 2020	SELL	$37.23 - $50.97 $2.41 Million - $3.29 Million	-64,607 Reduced 10.99%	523,414 $25.9 Million
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $1.96 Million - $3.18 Million	67,949 Added 13.07%	588,021 $22.6 Million
Q1 2020 May 14, 2020	SELL	$25.53 - $70.14 $341,157 - $937,280	-13,363 Reduced 2.51%	520,072 $16.1 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $1.18 Million - $1.42 Million	21,698 Added 4.24%	533,435 $29.1 Million
Q3 2019 Nov 13, 2019	BUY	$58.58 - $83.91 $2.53 Million - $3.62 Million	43,182 Added 9.22%	511,737 $32 Million
Q2 2019 Aug 13, 2019	SELL	$63.59 - $78.71 $571,101 - $706,894	-8,981 Reduced 1.88%	468,555 $35.3 Million
Q1 2019 May 13, 2019	BUY	$50.75 - $80.54 $291,812 - $463,105	5,750 Added 1.22%	477,536 $37.4 Million
Q4 2018 Feb 12, 2019	SELL	$52.18 - $67.93 $213,885 - $278,445	-4,099 Reduced 0.86%	471,786 $26.5 Million
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $510,179 - $914,790	13,380 Added 2.89%	475,885 $30.9 Million
Q2 2018 Sep 18, 2018	SELL	$27.62 - $44.51 $61,012 - $98,322	-2,209 Reduced 0.48%	462,505 $18.8 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $1.63 Million - $2.63 Million	59,111 Added 14.57%	464,714 $18.9 Million
Q1 2018 May 09, 2018	BUY	$26.05 - $34.5 $1.02 Million - $1.35 Million	39,029 Added 10.65%	405,603 $12.5 Million
Q4 2017 Feb 14, 2018	SELL	$24.5 - $36.01 $142,198 - $209,002	-5,804 Reduced 1.56%	366,574 $9.4 Million
Q3 2017 Nov 13, 2017	BUY	$31.26 - $42.03 $11.6 Million - $15.7 Million	372,378	372,378 $12.3 Million

Others Institutions Holding GKOS

# of Institutions

336

Shares Held

47M

Call Options Held

126K

Put Options Held

184K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.6B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Glaukos Corp Transaction History